XML 373 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Impairment
12 Months Ended
Dec. 31, 2024
Disclosure of impairment loss and reversal of impairment loss [abstract]  
Impairment Note 14: Impairment
Year ended 31 December 2024
Stage 1
£m
Stage 2
£m
Stage 3
£m
POCI
£m
Total
£m
Loans and advances to banks
(7)
(7)
Loans and advances to customers
(147)
(289)
949
(6)
507
Debt securities
(4)
(2)
(6)
Financial assets at amortised cost
(158)
(291)
949
(6)
494
Financial assets at fair value through other comprehensive income
(3)
(3)
Other assets
(9)
(9)
Loan commitments and financial guarantees
(18)
(33)
(51)
Total impairment charge (credit)
(188)
(324)
949
(6)
431
Year ended 31 December 2023
Stage 1
£m
Stage 2
£m
Stage 3
£m
POCI
£m
Total
£m
Loans and advances to banks
(5)
(2)
(7)
Loans and advances to customers
261
(281)
414
(73)
321
Debt securities
1
1
Financial assets at amortised cost
256
(282)
414
(73)
315
Financial assets at fair value through other comprehensive income
(2)
(2)
Other assets
(10)
(10)
Loan commitments and financial guarantees
27
(25)
(2)
Total impairment charge (credit)
281
(307)
402
(73)
303
Year ended 31 December 2022
Stage 1
£m
Stage 2
£m
Stage 3
£m
POCI
£m
Total
£m
Loans and advances to banks
12
2
14
Loans and advances to customers
(217)
694
883
(9)
1,351
Debt securities
7
7
Financial assets at amortised cost
(198)
696
883
(9)
1,372
Financial assets at fair value through other comprehensive income
6
6
Other assets
22
22
Loan commitments and financial guarantees
24
99
(1)
122
Total impairment (credit) charge
(168)
795
904
(9)
1,522
The impairment charge includes a £24 million charge (2023: £73 million charge; 2022: £nil) in respect of residual value impairment and
voluntary terminations within the Group’s UK Motor Finance business.